New research attempts to answer some of the mystery related to the causes and impact of hypercalcemia in patients with newly diagnosed multiple myeloma. Hypercalcemia is caused by many factors in ...

Please provide your email address to receive an email when new articles are posted on . A new clinical practice guideline from the Endocrine Society recommends treatment with IV bisphosphonates or ...

Hypercalcemia of malignancy (HCM) is the most common metabolic complication seen in patients with cancer, and is associated with a high degree of morbidity and mortality. It affects an estimated 2%–30 ...

The authors used Ovid Medline to search for human trials on hypercalcemia and furosemide from 1950 to April 2008, and articles related to bisphosphonates and hypercalcemia during the same period.

Hypercalcemia affects up to 30% of patients with cancer. 1 It has been seen in most cancers but is most common in patients with non-small cell lung cancer, breast cancer, multiple myeloma, head and ...

Q: Which doctor should you consult for hypercalcemia? A: You should consult a General Physician (Internal Medicine – MDs) who may further refer you to an Endocrinologist for treating hypercalcemia. A: ...

Familial hypocalciuric hypercalcemia: It is a condition which is hereditary and runs in families and is characterized by 3 things – hypercalcemia (S.Ca >10.2 mg/dl), hypocalciuria (Ca excretion rate 0 ...